In this article, I will provide a discounted cash flow (NYSE:DCF) valuation for Johnson & Johnson (JNJ). I will first discuss Q1 results because it gives context to the cash flow forecast and provides more insight into expectations for 2018 and beyond. I will then go on to discuss some of the key value drivers for Johnson & Johnson after which I provide a cash flow forecast. I use three different methods to obtain the terminal value. I average the results of these three methods to correct for potential outliers and provide a more complete terminal value. Based on the forecast and these methods, Johnson & Johnson is worth $144 and has 18% upside potential. Lastly, I provide three sensitivity analyses to show the effect of using various discount rates, multiples, and terminal growth rates.
READ FULL ARTICLE HERE

